CLINICAL_TRIALS
trial_result
· 2021-04-27
Clinical Trial Update: Phase II Study of Cediranib (AZD2171) in Patients With Alveolar Soft Part Sarcoma [Phase 2]
Summary
Phase II trial update reporting results for Cediranib (AZD2171) in alveolar soft part sarcoma; study completed and results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Cancer Institute (NCI) | Conditions: Sarcoma, Alveolar Soft Part | Phase 2 | Status: COMPLETED | Results posted: 2021-04-27